Trials / Completed
CompletedNCT03769753
Trial of IRE in Cholangiocarcinoma
Trial Of IRE in Cholangiocarcinoma (TOnIC): Phase II
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test any good and bad side effects of surgery using IRE to treat cancer of the bile duct.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | IRE Device | For use in ablating soft tissue |
Timeline
- Start date
- 2018-12-05
- Primary completion
- 2021-08-16
- Completion
- 2021-08-16
- First posted
- 2018-12-07
- Last updated
- 2022-09-10
- Results posted
- 2022-09-10
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03769753. Inclusion in this directory is not an endorsement.